Results 1 to 10 of about 8,781 (113)

Population Pharmacokinetics of Primaquine in the Korean Population [PDF]

open access: yesPharmaceutics, 2021
While primaquine has long been used for malaria treatment, treatment failure is common. This study aims to develop a population pharmacokinetic model of primaquine and its metabolite, carboxyprimaquine, and examine factors influencing pharmacokinetic variability.
Woo-Yul Lee   +6 more
openaire   +4 more sources

Pharmacokinetics and population pharmacokinetics in pediatric oncology [PDF]

open access: yesPediatric Blood & Cancer, 2019
AbstractPharmacokinetic research has become increasingly important in pediatric oncology as it can have direct clinical implications and is a crucial component in individualized medicine. Population pharmacokinetics has become a popular method especially in children, due to the potential for sparse sampling, flexible sampling times, computing of ...
Sebastiaan D.T. Sassen   +3 more
openaire   +5 more sources

Population pharmacokinetics of pomalidomide [PDF]

open access: yesThe Journal of Clinical Pharmacology, 2015
AbstractA population pharmacokinetic (PPK) model of pomalidomide was developed and the influence of demographic and disease‐related covariates on PPK parameters was assessed based on data from 6 clinical trials of pomalidomide (dose range, 0.5–10 mg) in healthy participants (n = 96) and patients with multiple myeloma (MM; n = 144).
Li, Yan   +5 more
openaire   +2 more sources

Population pharmacokinetics of exenatide [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2016
AimThe aim of the present analysis was to develop a core population pharmacokinetic model for the pharmacokinetic properties of immediate‐release (IR) exenatide, which can be used in subsequent analyses of novel sustained‐release formulations.MethodsData from eight clinical trials, evaluating a wide range of doses and different administration routes ...
Cirincione, Brenda, Mager, Donald E.
openaire   +2 more sources

Population Pharmacokinetics of Daptomycin [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2004
ABSTRACT Data from subjects in nine phase 1 ( n = 153) and six phase 2/3 ( n = 129) clinical trials were combined to identify factors contributing to interindividual variability in daptomycin pharmacokinetics (PK). Over 30 covariates were considered.
Barry, Dvorchik   +5 more
openaire   +2 more sources

Population Pharmacokinetics of Teicoplanin in Children [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2014
ABSTRACT Teicoplanin is frequently administered to treat Gram-positive infections in pediatric patients. However, not enough is known about the pharmacokinetics (PK) of teicoplanin in children to justify the optimal dosing regimen.
Ramos-Martin V.   +14 more
openaire   +6 more sources

Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL) [PDF]

open access: bronze, 2023
Brendan C. Bender   +13 more
openalex   +1 more source

Population pharmacokinetics: an overview

open access: yesAustralian Prescriber, 2014
The pharmacokinetics of a drug refers to how it is handled by the body. This includes absorption, distribution, metabolism and elimination.
openaire   +3 more sources

Application of population pharmacokinetics to cladribine [PDF]

open access: yesBMC Pharmacology, 2005
Abstract Background The nucleoside analog cladribine is used for the treatment of a variety of indolent B- and T-cell lymphoid malignancies. The primary aim of the study was to evaluate the population distribution of pharmacokinetic parameters in patients undergoing treatment with cladribine and to detect
Lindemalm, Synnöve   +5 more
openaire   +2 more sources

Tobramycin population pharmacokinetics in neonates* [PDF]

open access: yesClinical Pharmacology & Therapeutics, 1997
To establish a tobramycin dosing schedule for neonates of various gestational ages.This was a retrospective study with prospective validation. A retrospective study in 470 neonates, with suspected septicemia in the first week of life, was performed. All patients received tobramycin according to the following scheme: neonates with a gestational age of ...
de Hoog, Matthijs   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy